High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial
- PMID: 34601619
- DOI: 10.1007/s00134-021-06501-3
High dose coupled plasma filtration and adsorption in septic shock patients. Results of the COMPACT-2: a multicentre, adaptive, randomised clinical trial
Abstract
Purpose: This study aimed at evaluating the efficacy and safety of high-dose (> 0.2 L/kg of treated plasma per day) coupled plasma filtration-adsorption (CPFA) in treating patients with septic shock.
Methods: Multicentre, randomised, adaptive trial, performed in 12 Italian intensive care units (ICUs). Patients aged 14 or more, admitted to the ICU with septic shock, or had developed it during the stay were eligible. The final outcome was mortality at discharge from the last hospital at which the patient received care.
Results: Between May 2015, and October 2017, 115 patients were randomised. The first interim analysis revealed a number of early deaths, prompting an unplanned analysis. Last hospital mortality was non-significantly higher in the CPFA (55.6%) than in the control group (46.2%, p = 0.35). The 90-day survival curves diverged in favour of the controls early after randomisation and remained separated afterwards (p = 0.100). An unplanned analysis showed higher mortality in CPFA compared to controls among patients without severe renal failure (p = 0.025); a dose-response relationship was observed between treated plasma volume and mortality (p = 0.010).
Conclusion: The COMPACT-2 trial was stopped due to the possible harmful effect of CPFA in patients with septic shock. The harmful effect, if present, was particularly marked in the early phase of septic shock. Patients not requiring renal replacement therapy seemed most exposed to the possible harm, with evidence of a dose-response effect. Until the mechanisms behind these results are fully understood, the use of CPFA for the treatment of patients with septic shock is not recommended.
Trial registration: ClinicalTrials.gov NCT01639664.
Keywords: Continuous renal replacement therapy (CRRT); Coupled plasma filtration-adsorption; Extracorporeal blood purification techniques; Intensive care medicine; Septic shock.
© 2021. Springer-Verlag GmbH Germany, part of Springer Nature.
Comment in
-
Unraveling the secret of re-balancing homeostasis in sepsis: a critical view on extracorporeal blood purification modalities.Intensive Care Med. 2022 Jan;48(1):130-132. doi: 10.1007/s00134-021-06560-6. Epub 2021 Oct 28. Intensive Care Med. 2022. PMID: 34713314 Free PMC article. No abstract available.
References
-
- Singer M, Deutschman CS, Seymour CW et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA 315:801–810. https://doi.org/10.1001/jama.2016.0287 - DOI - PubMed - PMC
-
- Rhodes A, Evans LE, Alhazzani W et al (2017) Surviving sepsis campaign: international guidelines for management of sepsis and septic shock: 2016. Crit Care Med 45:486–552. https://doi.org/10.1097/CCM.0000000000002255 - DOI - PubMed - PMC
-
- Franchi M, Giacalone M, Traupe I et al (2016) Coupled plasma filtration adsorption improves hemodynamics in septic shock. J Crit Care 33:100–105. https://doi.org/10.1016/j.jcrc.2016.02.005 - DOI - PubMed
-
- Tetta C, Gianotti L, Cavaillon JM et al (2000) Coupled plasma filtration-adsorption in a rabbit model of endotoxic shock. Crit Care Med 28:1526–1533. https://doi.org/10.1097/00003246-200005000-00045 - DOI - PubMed
-
- Formica M, Olivieri C, Livigni S et al (2003) Hemodynamic response to coupled plasmafiltration-adsorption in human septic shock. Intensive Care Med 29:703–708. https://doi.org/10.1007/s00134-003-1724-0 - DOI - PubMed
Publication types
MeSH terms
Associated data
LinkOut - more resources
Full Text Sources
Medical
